ɪn ɐ tˈɪʃuː mˈaɪkɹoʊɚɹˌeɪ kəntˈeɪnɪŋ twˈɛnti wˈʌn kɔːɹdˈoʊməz plˈeɪtlɪtdᵻɹˈaɪvd ɡɹˈoʊθ fˈæktɚ ɹᵻsˈɛptɚbˈeɪɾə pˌiːdˌiːdʒˈiːˌɛfˈɑːɹbˈiː, ˌɛpɪdˈɜːməl ɡɹˈoʊθ fˈæktɚ ɹᵻsˈɛptɚ ˈɛɡfɚ, kˌeɪˌaɪtˈiː sˌiːdˈiː wˈʌnhˈʌndɹɪd sˈɛvəntˌiːn ænd hɜː tˈuː wɜː dɪtˈɛktᵻd ɪn wˈʌnhˈʌndɹɪd pɚsˈɛnt, sˈɪksti sˈɛvən pɚsˈɛnt, θˈɜːɾi θɹˈiː pɚsˈɛnt ænd zˈiəɹoʊ pɚsˈɛnt ʌv kˈeɪsᵻz, ɹᵻspˈɛktɪvli.
In a tissue microarray containing 21 chordomas Platelet-derived growth factor receptor-beta (PDGFR-b), epidermal growth factor receptor (EGFR), KIT (CD117) and HER2 were detected in 100%, 67%, 33% and 0% of cases, respectively.